top of page


Welcoming the New Kid on the Block; A Phase IIb Study of DDFPe in Large Vessel Strokes
The design for an efficient Phase IIb clinical trial in stroke to test DDFPe in patients with Large Vessel Occlusions.


Dodecafluoropentane Emulsion in Acute Ischemic Stroke: A Phase Ib/II Trial
This randomized, placebo-controlled, double-blind, dose-escalation clinical trial in acute ischemic stroke patients was designed to...


NuvOx Pharma’s NanO2 Shows Positive Results in Phase Ib/II Stroke Trial
Positive results of NuvOx Pharma’s NanO2 (DDFPe) in the treatment of stroke have been published at the International Stroke Conference. A...


Dodecafluoropentane Improves Neurological Function Following Anterior Ischemic Stroke
DDFPe reduces infarct volume and neurological function following anterior ischemic stroke.
bottom of page
